Assessing the Effects of Ongoing Ocrelizumab (OCR) Therapy on Fatigue and Cognition in Veterans With Multiple Sclerosis
Clinical trial NCT07181811 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07181811
- Sponsor
- Anza Memon
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-30
- Primary completion
- 2028-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.